2,032
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Vascular calcification on the risk of kidney stone: a meta-analysis

, , ORCID Icon, , &
Article: 2183727 | Received 26 Sep 2022, Accepted 17 Feb 2023, Published online: 03 Mar 2023

References

  • Thongprayoon C, Krambeck AE, Rule AD. Determining the true burden of kidney stone disease. Nat Rev Nephrol. 2020;16:736–746.
  • Liu Y, Chen Y, Liao B, et al. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018;5:205–214.
  • Sorokin I, Mamoulakis C, Miyazawa K, et al. Epidemiology of stone disease across the world. World J Urol. 2017;35(9):1301–1320.
  • Xu LHR, Adams-Huet B, Poindexter JR, et al. Temporal changes in kidney stone composition and in risk factors predisposing to stone formation. J Urol. 2017;197(6):1465–1471.
  • Yang C, Wang H, Zhao X, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis. 2020;76(2):258–264.
  • Alexander RT, Hemmelgarn BR, Wiebe N, et al. Kidney stones and kidney function loss: a cohort study. BMJ. 2012;345:e5287.
  • Dhondup T, Kittanamongkolchai W, Vaughan LE, et al. Risk of ESRD and mortality in kidney and bladder stone formers. Am J Kidney Dis. 2018;72(6):790–797.
  • Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252.
  • Rule AD, Roger VL, Melton LJ, 3rd, et al. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol. 2010;21(10):1641–1644.
  • Ferraro PM, Taylor EN, Eisner BH, et al. History of kidney stones and the risk of coronary heart disease. JAMA. 2013;310(4):408–415.
  • Kim SY, Bang WJ, Min C, et al. Association of nephrolithiasis with the risk of cardiovascular diseases: a longitudinal follow-up study using a national health screening cohort. BMJ Open. 2020;10(11):e040034.
  • Razavi AC, Agatston AS, Shaw LJ, et al. Evolving role of calcium density in coronary artery calcium scoring and atherosclerotic cardiovascular disease risk. JACC Cardiovasc Imaging. 2022;15(9):1648–1662.
  • Anugula D, Cardoso R, Grandhi GR, et al. Extra-coronary calcification and cardiovascular events: what do we know and where are we heading? Curr Atheroscler Rep. 2022;24(10):755–766.
  • O'Connor SD, Graffy PM, Zea R, et al. Does nonenhanced CT-based quantification of abdominal aortic calcification outperform the Framingham risk score in predicting cardiovascular events in asymptomatic adults? Radiology. 2019;290(1):108–115.
  • Lanzer P, Hannan FM, Lanzer JD, et al. Medial arterial calcification: JACC state-of-the-Art review. J Am Coll Cardiol. 2021;78:1145–1165.
  • Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327(16):1141–1152.
  • Carbone A, Al Salhi Y, Tasca A, et al. Obesity and kidney stone disease: a systematic review. Minerva Urol Nefrol. 2018;70(4):393–400.
  • Witting C, Langman CB, Assimos D, et al. Pathophysiology and treatment of enteric hyperoxaluria. Clin J Am Soc Nephrol. 2021;16:487–495.
  • Liu CJ, Cheng CW, Tsai YS, et al. Crosstalk between renal and vascular calcium signaling: the link between nephrolithiasis and vascular calcification. Int J Mol Sci. 2021;22(7):3590.
  • Yiu AJ, Callaghan D, Sultana R, et al. Vascular calcification and stone disease: a new look towards the mechanism. J Cardiovasc Dev Dis. 2015;2(3):141–164.
  • Letavernier E, Bouderlique E, Zaworski J, et al. Pseudoxanthoma elasticum, kidney stones and pyrophosphate: from a rare disease to urolithiasis and vascular calcifications. Int J Mol Sci. 2019;20(24):6353.
  • Saenz-Medina J, Munoz M, Rodriguez C, et al. Endothelial dysfunction: an intermediate clinical feature between urolithiasis and cardiovascular diseases. Int J Mol Sci. 2022;23(2):912.
  • Reiner AP, Kahn A, Eisner BH, et al. Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol. 2011;185(3):920–925.
  • Hsi RS, Spieker AJ, Stoller ML, et al. Coronary artery calcium score and association with recurrent nephrolithiasis: the Multi-Ethnic study of atherosclerosis. J Urol. 2016;195(4 Pt 1):971–976.
  • Stern KL, Ward RD, Li J, et al. Nonrenal systemic arterial calcification predicts the formation of kidney stones. J Endourol. 2019;33(12):1032–1034.
  • Schoenfeld D, Zhu D, Mohn L, et al. The relationship between vascular calcifications and urolithiasis in a large, multiethnic patient population. Urolithiasis. 2021;49(6):533–541.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
  • Lo CK, Mertz D, Loeb M. Newcastle-Ottawa scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14:45.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
  • Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785–794.
  • Kim S, Chang Y, Sung E, et al. Association between sonographically diagnosed nephrolithiasis and subclinical coronary artery calcification in adults. Am J Kidney Dis. 2018;71(1):35–41.
  • Patil S, Maheshwari S, Khandelwal S, et al. Prevalence of calcified carotid artery atheromas on panoramic radiographs of renal stone patients. Saudi J Kidney Dis Transpl. 2016;27(1):62–66.
  • Li B, Tang Y, Zhou L, et al. Association between aortic calcification and the presence of kidney stones: calcium oxalate calculi in focus. Int Urol Nephrol. 2022;54(8):1915–1923.
  • Shavit L, Girfoglio D, Vijay V, et al. Vascular calcification and bone mineral density in recurrent kidney stone formers. Clin J Am Soc Nephrol. 2015;10(2):278–285.
  • Tanaka T, Hatakeyama S, Yamamoto H, et al. Clinical relevance of aortic calcification in urolithiasis patients. BMC Urol. 2017;17(1):25.
  • Hermann DM, Gronewold J, Lehmann N, Heinz Nixdorf Recall Study Investigative Group, et al. Coronary artery calcification is an independent stroke predictor in the general population. Stroke. 2013;44(4):1008–1013.
  • Davila JA, Johnson CD, Behrenbeck TR, et al. Assessment of cardiovascular risk status at CT colonography. Radiology. 2006;240(1):110–115.
  • Bastos Goncalves F, Voute MT, Hoeks SE, et al. Calcification of the abdominal aorta as an independent predictor of cardiovascular events: a meta-analysis. Heart. 2012;98(13):988–994.
  • Liu Y, Li S, Zeng Z, et al. Kidney stones and cardiovascular risk: a meta-analysis of cohort studies. Am J Kidney Dis. 2014;64(3):402–410.
  • Domingos F, Serra A. Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant. 2011;26(3):864–868.
  • Amin A, Rejjal A, McDonald P, et al. Nephrocalcinosis, cholelithiasis, and umbilical vein calcification in a premature-infant. Abdom Imaging. 1994;19(6):559–560.
  • Bos D, Arshi B, van den Bouwhuijsen QJA, et al. Atherosclerotic carotid plaque composition and incident stroke and coronary events. J Am Coll Cardiol. 2021;77(11):1426–1435.
  • Villa-Bellosta R. Vascular calcification: key roles of phosphate and pyrophosphate. Int J Mol Sci. 2021;22(24):13536.
  • Lieske JC, Rule AD, Krambeck AE, et al. Stone composition as a function of age and sex. Clin J Am Soc Nephrol. 2014;9(12):2141–2146.
  • Mulay SR, Eberhard JN, Pfann V, et al. Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice. Am J Physiol Renal Physiol. 2016;310(8):F785–F795.
  • Khan SR, Canales BK, Dominguez-Gutierrez PR. Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation. Nat Rev Nephrol. 2021;17(6):417–433.
  • Khan SR. Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Transl Androl Urol. 2014;3:256–276.